Skip to main content
Fig. 8 | BMC Pulmonary Medicine

Fig. 8

From: The combination therapy of isomucronulatol 7-O-beta-glucoside (IMG) and CEP-9722 targeting ferroptosis-related biomarkers in non-small cell lung cancer (NSCLC)

Fig. 8

Network pharmacology and molecular docking of active ingredients of HMM and ferroptosis-related signature genes. A The flow of network pharmacology and molecular docking. B The overlap genes between 206 targeted genes of active ingredients in HMM and 14 ferroptosis-related biomarkers. C The 3D structure model of small molecule and protein

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us